Christopher Winter
6Patents
2h-index
19Co-inventors
44Inventor score
Filing activity: Nov 23, 2004 → Dec 23, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8852590B2 | Compositions and methods for treating cancer | Human Necessities | 3 | Active |
| US10766955B2 | Anti-TGF-β antibodies and their use | Chemistry; Metallurgy | 2 | Active |
| US11242384B2 | Anti-TGF-beta antibodies and their use | Chemistry; Metallurgy | 2 | Active |
| US8632962B2 | PLKS as modifiers of the beta catenin pathway and methods of use | Physics | 0 | Active |
| US12049496B2 | Anti-TGF-beta antibodies and their use | Chemistry; Metallurgy | 0 | Active |
| US9110082B2 | Methods for the identification and treatment of patients sensitive to anti IGF-1R inhibition therapy | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.